MLNT
Melinta Therapeutics, Inc. Common Stock
MLNT
MLNT
Delisted
MLNT was delisted on the 10th of January, 2020.
37 hedge funds and large institutions have $584K invested in Melinta Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
94% less capital invested
Capital invested by funds: $9.43M → $584K (-$8.85M)
Holders
37
Holding in Top 10
–
Calls
$289K
Puts
$45K
Top Buyers
| 1 | +$22.2K | |
| 2 | +$21.8K | |
| 3 | +$15.5K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$15K |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$12K |
Top Sellers
| 1 | -$2.22M | |
| 2 | -$1.69M | |
| 3 | -$374K | |
| 4 |
Bank of New York Mellon
New York
|
-$188K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$139K |